Urogen Pharma Ltd. (URGN) — SC 13D/A Filings
All SC 13D/A filings from Urogen Pharma Ltd.. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (2)
-
Pontifax Amends UroGen Pharma Holdings Filing
— Nov 18, 2024 Risk: low
Pontifax Management III G.P. (2011) Ltd. filed an amendment to its Schedule 13D on November 18, 2024, regarding its holdings in UroGen Pharma Ltd. The filing in -
Arkin Amends UroGen Pharma Stake Filing
— Feb 22, 2024 Risk: low
Moshe Arkin, through Arkin Communications Ltd., filed an Amendment No. 4 to Schedule 13D for UroGen Pharma Ltd. on February 22, 2024. The filing indicates a cha
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX